Saltar al contenido
Merck

Y0001088

Cyclopentolate for system suitability

European Pharmacopoeia (EP) Reference Standard

Sinónimos:

Cyclopentolate hydrochloride, 2-Dimethylaminoethyl 1-hydroxy-α-phenylcyclopentaneacetate

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Fórmula empírica (notación de Hill):
C17H25NO3 · HCl
Número de CAS:
Peso molecular:
327.85
Número MDL:
Código UNSPSC:
41116107
ID de la sustancia en PubChem:
NACRES:
NA.24

grado

pharmaceutical primary standard

familia API

cyclopentolate

fabricante / nombre comercial

EDQM

aplicaciones

pharmaceutical (small molecule)

formato

neat

temp. de almacenamiento

2-8°C

cadena SMILES

Cl.CN(C)CCOC(=O)C(c1ccccc1)C2(O)CCCC2

InChI

1S/C17H25NO3.ClH/c1-18(2)12-13-21-16(19)15(14-8-4-3-5-9-14)17(20)10-6-7-11-17;/h3-5,8-9,15,20H,6-7,10-13H2,1-2H3;1H

Clave InChI

RHKZVMUBMXGOLL-UHFFFAOYSA-N

Información sobre el gen

human ... CHRM3(1131)

¿Está buscando productos similares? Visita Guía de comparación de productos

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicación

Cyclopentolate for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Envase

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Otras notas

Sales restrictions may apply.

Choose from one of the most recent versions:

Certificados de análisis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Zhen-Ying Cheng et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 252(12), 1939-1946 (2014-08-15)
To investigate the effects of the relatively selective GABAAOr receptor antagonist (1,2,5,6-tetrahydropyridin-4-yl) methylphosphinic acid (TPMPA) on form-deprivation myopia (FDM) in guinea pigs. A diffuser was applied monocularly to 30 guinea pigs from day 10 to 21. The animals were randomized
Yosuke Ito et al.
The Journal of veterinary medical science, 77(2), 155-160 (2014-11-07)
The purpose of this study was to investigate the effects of sevoflurane concentration on canine visual evoked potentials with pattern stimulation (P-VEPs). Six clinically normal laboratory-beagle dogs were used. The minimum alveolar concentration (MAC) of sevoflurane was detected from all
Marije J Hoornweg et al.
European journal of ophthalmology, 24(6), 940-947 (2014-04-15)
To compare intralesional corticosteroid (IC) injections with oral propranolol in children with periorbital infantile hemangioma (IH). Children were diagnosed with IH and treated with IC (n = 29) or propranolol (n = 14). In cases in which no further improvement
Jacky W Y Lee et al.
Medicine, 94(12), e699-e699 (2015-03-31)
The purpose of this study was to investigate the peripapillary retinal nerve fiber layer (RNFL) thickness in myopic, emmetropic, and hyperopic children using optical coherence tomography. Two-hundred one right eyes of subjects aged 4 to 18 years were divided into
Yakov Goldich et al.
American journal of ophthalmology, 159(1), 155-159 (2014-12-03)
To compare objective and subjective outcomes after Descemet membrane endothelial keratoplasty (DMEK) and Descemet stripping automated endothelial keratoplasty (DSAEK) in the fellow eye of the same patients. Single-center, retrospective case series. Seventeen patients with bilateral Fuchs endothelial dystrophy who underwent

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico